CoChat

GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis

Mercimek-Mahmutoglu, S., Stoeckler-Ipsiroglu, S., Adami, A., Appleton, R., Araújo, H. Caldeira, Duran, M., Ensenauer, R., Fernandez-Alvarez, E., Garcia, P., Grolik, C., Item, C. B., Leuzzi, V., Marquardt, I., Mühl, A., Saelke-Kellermann, R. A., Salomons, G. S., Schulze, A., Surtees, R., van der Knaap, M. S., Vasconcelos, R., Verhoeven, N. M., Vilarinho, L., Wilichowski, E., Jakobs, C. · 2006 · Neurology
Cited by 158

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Guanidinoactetate methyltransferase (GAMT) deficiency is an autosomal recessive disorder of creatine synthesis. The authors analyzed clinical, biochemical, and molecular findings in 27 patients. METHODS: The authors collected data from questionnaires and literature reports. A score including degree of intellectual disability, epileptic seizures, and movement disorder was developed and used to classify clinical phenotype as severe, moderate, or mild. Score and biochemical data were assessed before and during treatment with oral creatine substitution alone or with additional dietary arginine restriction and ornithine supplementation. RESULTS: Intellectual disability, epileptic seizures, guanidinoacetate accumulation in body fluids, and deficiency of brain creatine were common in all 27 patients. Twelve patients had severe, 12 patients had moderate, and three patients had mild clinical phenotype. Twenty-one of 27 (78%) patients had severe intellectual disability (estimated IQ 20 to 34). There was no obvious correlation between severity of the clinical phenotype, guanidinoacetate accumulation in body fluids, and GAMT mutations. Treatment resulted in almost normalized cerebral creatine levels, reduced guanidinoacetate accumulation, and in improvement of epilepsy and movement disorder, whereas the degree of intellectual disability remained unchanged. CONCLUSION: Guanidinoactetate methyltransferase deficiency should be considered in patients with unexplained intellectual disability, and urinary guanidinoacetate should be determined as an initial diagnostic approach.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000234852.43688.bf

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 24

  1. Von Figura K Hanefeld F Isbrandt D Stöckler-Ipsiroglu S. Guanidinoacetate methyltransferase deficiency. In: Scriver CR Beaudet AL Sly WS Valle D eds. The metabolic and molecular basis of inherited disease 8th ed. New York: McGraw-Hill 2001:1897–1908.
  2. Stockler S, Isbrandt D, Hanefeld F, Schmidt B, von Figura K. Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am J Hum Genet 1996;58:914–922.
  3. 10.1016/S0026-0495(97)90215-8 · DOI
  4. 10.1006/mgme.2001.3257 · DOI · Paper page
  5. 10.1016/S0022-3476(97)70075-1 · DOI · Paper page
  6. 10.1002/1531-8249(200004)47:4<540::AID-ANA23>3.0.CO;2-K · DOI · Paper page
  7. 10.1212/WNL.55.9.1407 · DOI · Paper page
  8. 10.1002/ana.10455 · DOI
  9. 10.1016/j.ymgme.2005.09.017 · DOI
  10. Vilarinho L, Valongo C, Cardoso ML, et al. Five new Portuguese patients with guanidinoacetate methyltransferase deficiency: biochemical, enzymatic and molecular data. J Inherit Metab Dis 2004;27(suppl 1):213.
  11. 10.1002/ajmg.a.30226 · DOI
  12. 10.1016/S0731-7085(98)00280-5 · DOI
  13. 10.1016/S0009-8981(01)00480-6 · DOI
  14. Korall H, Göggerle M, Frauendienst-Egger G, Trefz FK. Multiple disease categories screening analysis (multiscan) in urine by tandem mass spectrometry. J Inherit Metab Dis 2000;23(suppl 1):8.
  15. 10.1016/0026-0495(92)90213-T · DOI
  16. 10.1016/S0009-8981(99)00182-5 · DOI
  17. 10.1373/clinchem.2003.022764 · DOI
  18. 10.1093/clinchem/48.5.767 · DOI
  19. Item CB, Mercimek-Mahmutoglu S, Battini R, et al. Characterisation of seven novel mutations in seven patients with GAMT deficiency. Hum Mutat 2004;23:524.
  20. Stockler-Ipsiroglu S Battini R de Grauw T Schulze A. Disorder of creatine metabolism. In: Blau N Hoffmann GF Leonard J Clarke JTR eds. Physician’s guide to the treatment and follow-up of metabolic diseases. Heidelberg Germany: Springer-Verlag 2005:255–265. · DOI
  21. 10.1023/A:1022443503883 · DOI · Paper page
  22. 10.1023/A:1024453704800 · DOI
  23. Walker JB. Creatine: biosynthesis, regulation, and function. Adv Enzymol 1979;50:177–242.
  24. 10.1023/A:1022491419813 · doi:10.1023/a:1022491419813

Cited by

See all 158

Metadata

Authors
Mercimek-Mahmutoglu, S., Stoeckler-Ipsiroglu, S., Adami, A., Appleton, R., Araújo, H. C., Duran, M., Ensenauer, R., Fernandez-Alvarez, E., Garcia, P., Grolik, C., Item, C. B., Leuzzi, V., Marquardt, I., Mühl, A., Saelke-Kellermann, R. A., Salomons, G. S., Schulze, A., Surtees, R., van der Knaap, M. S., Vasconcelos, R., Verhoeven, N. M., Vilarinho, L., Wilichowski, E., & Jakobs, C.
Venue
Neurology
Published
2006-08-08
Volume
67
Issue
3
Pages
480-484
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2167247297
Cited by
158
References
4
FWCI
6.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis. https://app.cochat.ai/papers/10.1212/01.wnl.0000234852.43688.bf
The paper
Mercimek-Mahmutoglu, S., Stoeckler-Ipsiroglu, S., Adami, A., Appleton, R., Araújo, H. C., Duran, M., Ensenauer, R., Fernandez-Alvarez, E., Garcia, P., Grolik, C., Item, C. B., Leuzzi, V., Marquardt, I., Mühl, A., Saelke-Kellermann, R. A., Salomons, G. S., Schulze, A., Surtees, R., van der Knaap, M. S., . . . Jakobs, C. (2006). GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis. Neurology. https://doi.org/10.1212/01.wnl.0000234852.43688.bf

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.